Cargando…

Hepatocellular carcinoma biomarkers, an imminent need

Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. The identification of novel, highly specific and more sensitive biomarkers for HCC is crucial because existing ones are deficient and non-confirmatory without histological bi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zamora-León, S Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603452/ https://www.ncbi.nlm.nih.gov/pubmed/34853655 http://dx.doi.org/10.4251/wjgo.v13.i11.1847

Ejemplares similares

Muscle composition and the imminent mortality risk after hip fracture
por: Wang, Ling, et al.
Publicado: (2022)

Number of COVID-19 patients classified as cured: an imminent danger for the population
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2020)

The unique landscape of coronavirus disease 2019 coagulopathy and imminent bleedings at unusual sites: Pathophysiology matters
por: Paschou, Eleni, et al.
Publicado: (2022)

Apply the Brighton Criteria for Diagnosing SARS-CoV-2 Associated GBS Despite Pandemia-Imminent Restrictions
por: Finsterer, Josef
Publicado: (2022)

Natriuretic peptide biomarkers in the imminent development of preeclampsia
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2023)

Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
por: Nath, Lekshmi R, et al.
Publicado: (2021)

COVID-19 self-testing in Brazil and the imminent risk of underreporting cases
por: Oliveira, Laura Alves Ribeiro, et al.
Publicado: (2023)

Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined
por: Li, Heming, et al.
Publicado: (2023)

Identification of IRF8 as an immune infiltration‐related biomarker in hepatocellular carcinoma by bioinformatics analysis
por: Zhang, Renyu, et al.
Publicado: (2022)

LHC: démarrage imminent
Publicado: (2008)

Risk Stratification for Imminent Risk of Death at the Time of Palliative Radiotherapy Consultation
por: Wu, Susan Y., et al.
Publicado: (2021)

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

The end of leprosy is not imminent, but it is on the horizon
por: Saunderson, Paul, et al.
Publicado: (2022)

Circulating Beam in LHC Imminent!
Publicado: (2009)

The imminent role of microRNAs in salivary adenoid cystic carcinoma
por: Kumar, Pawan, et al.
Publicado: (2022)

Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
por: Huang, Cheng, et al.
Publicado: (2022)

Megestrol treatment in patients with hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2001)

Drug-eluting beads in hepatocellular carcinoma
por: Abe, Hiroyuki, et al.
Publicado: (2017)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

Almond Consumption and Inflammatory Biomarkers: A Need for Further Investigation
por: Petakh, Pavlo, et al.
Publicado: (2023)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Age- and gender-matched controls needed for platelet-based biomarker studies
por: Sabrkhany, Siamack, et al.
Publicado: (2022)

Which treatment to prevent an imminent fracture?
por: Laura, Iconaru, et al.
Publicado: (2021)

Osteoporosis – An Imminent Ethical and Legal Debacle?
por: Pai, Satvik N, et al.
Publicado: (2023)

Imminent science: what remains to be discovered
por: Bignami, Giovanni F
Publicado: (2014)

Risk Factors and Incidence of Hepatocellular Carcinoma in Southeast Iran
por: Saiedi Hosseini, Seyed Yasser
Publicado: (2011)

Hepatocellular carcinoma hidden by multiple infarcted regenerative nodules
por: Kim, Jin Ah, et al.
Publicado: (2016)

Rare Case of Hepatocellular Carcinoma Invading the Right Atrium
por: Alhawassi, Sami
Publicado: (2017)

Radical resection and reconstruction of the sternum for metastasis of hepatocellular carcinoma
por: Yoon, Young Chul, et al.
Publicado: (2020)

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
por: Thakral, Nimish, et al.
Publicado: (2020)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
por: Gupta, Tarana
Publicado: (2022)

Fibrolamellar hepatocellular carcinoma presenting with early recurrent thrombosis
por: Kundakcioglu, Hacer, et al.
Publicado: (2022)

Novel preoperative strategies to improve hepatocellular carcinoma resectability
por: Tustumi, Francisco, et al.
Publicado: (2023)

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering
por: Ali, Joham Surfraz, et al.
Publicado: (2020)

Reply: A morpho-molecular prognostic model for hepatocellular carcinoma
por: Srivastava, S, et al.
Publicado: (2013)

RE: Evaluation of Small Hepatocellular Carcinomas with Diffusion Weighted Imaging
por: Cuce, Ferhat, et al.
Publicado: (2013)

Usefulness of the MESH score in a European hepatocellular carcinoma cohort
por: Adhoute, Xavier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m1morafkgdqkncef2pl23rbj9h